Scientists trace path of bacterial toxins from the mouth to the brain and other tissues
Researchers are reporting new findings on how bacteria involved in gum disease can travel throughout the body, exuding toxins connected with Alzheimer’s disease, rheumatoid arthritis and aspiration pneumonia. They detected evidence of the bacteria in brain samples from people with Alzheimer’s and used mice to show that the bacterium can find its way from the mouth to the brain.
The bacterium, Porphyromonas gingivalis, is the bad actor involved in periodontitis, the most serious form of gum disease. These new findings underscore the importance of good dental hygiene as scientists seek ways to better control this common bacterial infection.
“Oral hygiene is very important throughout our life, not only for having a beautiful smile but also to decrease the risk of many serious diseases,” said Jan Potempa, PhD, DSc, a professor at the University of Louisville School of Dentistry and head of the department of microbiology at Jagiellonian University in Krakow, Poland. “People with genetic risk factors that make them susceptible to rheumatoid arthritis or Alzheimer’s disease should be extremely concerned with preventing gum disease.”
While previous researchers have noted the presence of P. gingivalis in brain samples from Alzheimer’s patients, Potempa’s team, in collaboration with Cortexyme, Inc., offers the strongest evidence to date that the bacterium may actually contribute to the development of Alzheimer’s disease. Potempa will present the research at the American Association of Anatomists annual meeting during the 2019 Experimental Biology meeting, held April 6-9 in Orlando, Fla.
The researchers compared brain samples from deceased people with and without Alzheimer’s disease who were roughly the same age when they died. They found P. gingivaliswas more common in samples from Alzheimer’s patients, evidenced by the bacterium’s DNA fingerprint and the presence of its key toxins, known as gingipains.
In studies using mice, they showed P. gingivalis can move from the mouth to the brain and that this migration can be blocked by chemicals that interact with gingipains. An experimental drug that blocks gingipains, known as COR388, is currently in phase 1 clinical trials for Alzheimer’s disease. Cortexyme, Inc. and Potempa’s team are working on other compounds that block enzymes important to P. gingivalis and other gum bacteria in hopes of interrupting their role in advancing Alzheimer’s and other diseases.
The researchers also report evidence on the bacterium’s role in the autoimmune disease rheumatoid arthritis, as well as aspiration pneumonia, a lung infection caused by inhaling food or saliva.
“P. gingivalis‘s main toxins, the enzymes the bacterium need to exert its devilish tasks, are good targets for potential new medical interventions to counteract a variety of diseases,” said Potempa. “The beauty of such approaches in comparison to antibiotics is that such interventions are aimed only at key pathogens, leaving alone good, commensal bacteria, which we need.”
P. gingivalis commonly begins to infiltrate the gums during the teenage years. About one in five people under age 30 have low levels of the bacterium in their gums. While it is not harmful in most people, if it grows to large numbers the bacteria provoke the body’s immune system to create inflammation, leading to redness, swelling, bleeding and the erosion of gum tissue.
Making matters worse, P. gingivalis even causes benign bacteria in the mouth to change their activities and further increase the immune response. Bacteria can travel from the mouth into the bloodstream through the simple act of chewing or brushing teeth.
The best way to prevent P. gingivalis from growing out of control is by brushing and flossing regularly and visiting a dental hygienist at least once a year, Potempa said. Smokers and older people are at increased risk for infection. Genetic factors are also thought to play a role, but they are not well understood.
The Latest on: P. gingivalis
via Google News
The Latest on: Gum disease
- Infectious Disease Specialist Concludes Lana Del Rey’s Mesh Face Mask Is “Interesting” But Ineffectiveon October 7, 2020 at 7:11 am
Lana Del Rey held a surprise book signing for her new poetry book Violet Bent Backwards Over The Grass at a Los Angeles Barnes & Noble. Photos from the signing went viral, mostly because Del Rey wore ...
- Gum Disease Could Increase Your Breast Cancer Riskon October 6, 2020 at 11:33 am
As if hot flashes and menopause aren’t enough, a recent study has found a link between periodontal (gum) disease: a 14% increase in cancer among older women and a 12% ...
- The Latest: Trump diagnosis proves testing alone not enoughon October 6, 2020 at 8:23 am
President Donald Trump’s coronavirus diagnosis proved that testing alone wasn’t enough to protect him. Mask wearing and social distancing are other key ingredients for preventing the spread of ...
- Dentures Market to Reach USD 3.82 Billion by 2027 on Account of Rise in Baby Boomer Populationon October 6, 2020 at 5:29 am
How much is the dentures market worth? The global dentures market is worth USD 3.82 billion by 2026. What was the value of the global market in 2019? The value of the market in 2019 was USD 2.33 ...
- The Latest: 15 vaccine clinical trials underway in Africaon October 6, 2020 at 4:36 am
JOHANNESBURG — Fifteen clinical trials of COVID-19 vaccines are underway across the African continent, according to a comment published in the journal Nature by Africa Centers for Disease Control and ...
- Researchers demonstrate how changing the stem cell response to inflammation may reverse periodontal diseaseon October 2, 2020 at 9:01 am
Periodontal disease, also known as gum disease, is a serious infection that affects nearly 50 percent of Americans aged 30 years and older. If left unchecked, periodontal disease can destroy the ...
- Forsyth researchers demonstrate how changing the stem cell response to inflammation may reverse periodontal diseaseon October 2, 2020 at 8:29 am
In new research published recently in the journal Frontiers in Immunology, Forsyth Institute scientists have discovered that a specific type of molecule may stimulate stem cells to regenerate, ...
- Periodontal Therapeutics Market 2020 Trends, Size and Share, Future Demands, Growth Factors, Emerging Technologies, Global Industry Forecast to 2023on September 25, 2020 at 2:30 am
Periodontal Therapeutics Market”research provides actionable intelligence on major parameters impacting the market, analyses the market performance of key companies, market dynamics of key segments, ...
- Rising Demand for Oral Care to flourish the Global Periodontal Market Growthon September 24, 2020 at 7:43 pm
Periodontal disease is a type of oral health problems, which is considered quite significant across the globe. The prevalence of this disease is highly attributed to geography, and affects almost 90% ...
- Cortexyme Announces GAIN Trial of Atuzaginstat in Alzheimer’s Disease Has Exceeded Study Enrollment Target of 570 Patientson September 24, 2020 at 5:00 am
Cortexyme, Inc. (Nasdaq: CRTX) today announced that its GAIN Trial for Alzheimer’s disease (AD) has exceeded its enrollment target of 570 patients. GA ...
via Bing News